Imperva (IMPV) Tops Q2 EPS by 19c

Imperva (NASDAQ: IMPV) reported Q2 EPS of $0.24, $0.19 better than the analyst estimate of $0.05. Revenue for the quarter came in at $74.4 million versus the consensus estimate of $74.33 million.

GUIDANCE:

Imperva sees Q3 2017 EPS of $0.22-$0.26, versus the consensus of $0.10. Imperva sees Q3 2017 revenue of $81-83 million, versus the consensus of $82.4 million.

Imperva sees FY 2017 EPS of $0.78-$0.82, versus the consensus of $0.45. Imperva sees FY 2017 revenue of $319.8-322.8 million, versus the consensus of $321.3 million.

For earnings history and earnings-related data on Imperva (IMPV) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Bernstein SocGen Group Upgrades Whitbread PLC. (WTB:LN) (WTBCF) to Market Perform
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance